IMS Health Inc. v. Sorrell

631 F. Supp. 2d 429, 2009 U.S. Dist. LEXIS 51753, 2009 WL 1587327
District Court, D. Vermont·Decided June 5, 2009·No. File 1:07-CV-188, 1:07-CV-220·Published·Cited by 1 cases

Opinion

RULING ON MOTION FOR INJUNCTION PENDING APPEAL (Paper 433)

J. GARVAN MURTHA, District Judge.

I. Introduction

Plaintiffs IMS Health Inc., Verispan, LLC, and Source Healthcare Analytics, Inc. claim Section 17 of Vermont’s Prescription Confidentiality Law, codified at Vt. Stat. Ann. tit 18, § 4631, is unconstitutional. On April 24, 2009, this Court entered Judgment (Paper 431) denying Plaintiffs’ motions for declaratory and injunctive relief (Papers 6, 61) as well as for summary judgment (Paper 168). Plaintiffs *431 have appealed that ruling and move for an injunction to enjoin enforcement of Section 17 pending appeal (Papers 433, 435). Defendants oppose their request (Paper 438).

II. Background

The Court assumes familiarity with the factual and procedural background of this case as detailed in this Court’s April 23, 2009 Memorandum Opinion and Order (631 F.Supp.2d 434 (D.Vt.2009),).

III. Analysis

In relevant part, Fed.R.Civ.P. 62(c), provides: “While an appeal is pending from ... [a] final judgment that grants, dissolves, or denies an injunction, the court may suspend, modify, restore, or grant an injunction during the pendency of the appeal.” The factors the Court must consider in deciding whether to grant an injunction are: (1) likelihood of success on the merits; (2) irreparable harm to the movant absent an injunction; (3) possibility of substantial harm to other interested parties caused by an injunction; and, (4) the public interest. N.Y. State Rest. Ass’n v. N.Y. City Bd. of Health, 545 F.Supp.2d 363, 365-66 (S.D.N.Y.2008) (quoting In re World Trade Ctr. Disaster Site Litig., 503 F.3d 167, 170 (2d Cir.2007)).

Granting injunctive relief is an extraordinary remedy. Silverstein v. Penguin Putnam, Inc., 368 F.3d 77, 84 (2d Cir.2004). The burden to demonstrate all four factors is on Plaintiffs as the moving parties. Their burden is high because they seek an extraordinary remedy to prevent enforcement of a statute this Court has previously upheld and is presumed valid. See Brown v. Gilmore, 533 U.S. 1301, 1303, 122 S.Ct. 1, 150 L.Ed.2d 782 (2001) (Rehnquist, Circuit Justice 2001) (refusing to issue an injunction pending certiorari where applicants sought injunction against enforcement of a “presumptively valid state statute.”). The decision to grant an injunction pending appeal is in the Court’s discretion. Fed.R.Civ.P. 62(c); Conn. Hosp. Ass’n v. O’Neill, 863 F.Supp. 59, 61 (D.Conn.1994).

A. Irreparable Harm

Plaintiffs point to the Elrod v. Burns line of authority for the proposition that the loss of First Amendment rights, for even a short time, constitutes irreparable injury. 427 U.S. 347, 373, 96 S.Ct. 2673, 49 L.Ed.2d 547 (1976); see also Tunick v. Safir, 209 F.3d 67, 87 (2d Cir.2000) (applying Elrod presumption in reviewing grant of preliminary injunction). The Court finds persuasive Defendants’ argument distinguishing that authority. In the cases Plaintiffs cite, the courts were dealing with a preliminary injunction application instead of an injunction pending appeal after a final decision on the merits. See Nat’l Ass’n of Mfrs. v. Taylor, 549 F.Supp.2d 68, 76 (D.D.C.2008); see also Hsu v. Roslyn Union Free Sch. Dist., 85 F.3d 839, 853 (2d Cir.1996) (noting irreparable harm inquiry depends on merits of claim(s)). Here, in contrast, the Court has thoroughly considered and rejected the merits of Plaintiffs’ claim that Section 17 impermissibly burdens First Amendment rights, including the possibility of harm to Plaintiffs’ rights. The attempt to resuscitate the same arguments in support of their motion for an injunction pending appeal is unavailing.

Further, the irreparable harm analysis in this case is distinct from other First Amendment cases because the issues are different. Section 17 does not compel speech. See, e.g., Int’l Dairy Foods Ass’n v. Amestoy, 92 F.3d 67, 72 (2d Cir.1996) (holding statute caused irreparable harm by compelling manufacturers’ speech). Also, it does not restrict speech on a matter of public concern. IMS Health Inc. v. Ayotte, 550 F.3d 42, 100 (1st Cir.2008) (noting New Hampshire’s similar law “re *432 stricts only private communications ... rather than a message disseminated to the public at large”) (Lipez, J., concurring). Rather, this Court specifically found the data restricted by Section 17 is used to “covertly influence[ ]” prescribers. (Paper 433, at 31-32.) Most importantly, Section 17 does not prevent the disclosure of all restricted data for all purposes; it prevents only the use of restricted data for marketing purposes.

The Court also is unpersuaded by Plaintiffs’ claim of harm flowing from the cost of compliance. As Defendants point out, Plaintiffs have previously complied with this law and a similar law in New Hampshire. Though it may not be as easy as “flipping a switch,” (Paper 433 at 6), duplicating a system should not be as costly as creating it in the first instance. See, e.g., Paper 433 at 7 (noting Source Healthcare was compliant when Section 17 was effective in 2008 and subsequently “undid” the work when the effective date was changed). Plaintiffs also argue this expended money constitutes irreparable harm because, under the Eleventh Amendment, the government is immune from damage suits and the expenses cannot be recouped. Spending money to comply with the law is simply a fact of doing business. See Pennsy Supply, Inc. v. Susquehanna River Basin Comm’n, No. 1:CV-06-2454, 2007 WL 551573, at *3 (M.D.Pa. Feb. 20, 2007) (plaintiff corporation’s costs to comply with a government regulation did not constitute irreparable harm).

For these reasons, the Court rejects Plaintiffs’ claims of irreparable harm and finds this factor weighs in favor of denying an injunction pending appeal.

B. Likelihood, of Success on the Merits

The parties dispute the degree to which Plaintiffs must demonstrate their likelihood of success. Plaintiffs, citing LaRouche v. Kezer, 20 F.3d 68

Free access — add to your briefcase to read the full text and ask questions with AI

IMS Health Inc. v. Sorrell, 631 F. Supp. 2d 429, 2009 U.S. Dist. LEXIS 51753, 2009 WL 1587327 (D. Vt. 2009).

631 F. Supp. 2d 429 (IMS Health Inc. v. Sorrell) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related